RecensMedical리센스메디컬
394420 · KOSDAQ · ₩394420 · 리센스메디컬
- Market cap
- ₩64B
- Enterprise value
- ₩65B
- P/E
- —
- P/B
- 3.2×
- Dividend yield
- 0.0%
- ROE
- −96.3%
- Net margin
- −216.6%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−85.5% from the high
₩5,780Today: ₩5,780 – ₩6,660₩39,900
Returns
- 1W−17.2%
- 1M−40.5%
- 3M−47.5%
- 6M−81.0%
- YTD−68.7%
- 1Y—
- Volume today
- 97,866
- 1.1× the 20-day average
- Traded today
- ₩587M
- Listed shares
- 10,999,701
- EPS (12 months)
- −₩1,738
- Earnings yield −30.1%
🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Why is it moving?
−8.4% on Oct 26, 2026.
- • Foreign investors bought a net ₩81M that day
We found no news, filing or broker report explaining it yet. Moves without news happen; it may come later.
Possible reasons, not certainties. Not financial advice.
Signals
Normal- BuzzNormalBuzz 45 of 100 (50 is a normal day for this stock).
- MomentumWeak-41.7% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
RecensMedical stock overview
RecensMedical (리센스메디컬, KRX: 394420) is listed on KOSDAQ, in the Medical & precision devices sector. Its shares closed at ₩5,780 on Oct 26, 2026, down 8.40% on the day, giving it a market value of ₩64B.
Key facts
- Market cap
- ₩64B
- Sector
- Medical & precision devices
- Latest price change
- −8.40%
- As of
- Oct 26, 2026
Quick answers about RecensMedical
- What is the market cap of RecensMedical?
- The market capitalisation of RecensMedical was ₩64B at the close on Oct 26, 2026.
- Who are the largest shareholders of RecensMedical?
- According to the latest official filings, the largest reported holders are Kim Geon-ho (21.71%, as of May 22, 2026); LB Investment (8.46%, as of Apr 6, 2026); KB Securities (5.33%, as of Apr 7, 2026).
- When is the next earnings report from RecensMedical?
- Korean companies rarely announce results dates in advance. Based on when RecensMedical filed the same report in past years, its next 1q results is expected around May 15, 2027.
Company profile
Loading data for this company — check back soon
- Korean name
- 리센스메디컬
- CEO
- 김건호, 최의경
- Founded
- Oct 2016
- Listed
- Mar 2026
- Listed shares
- 10,999,701
- Fiscal year ends
- Month 12
- Website
- recensmedical.co.kr/
Similar companies
- TSE131290 · ₩2.7T₩241,000−6.23%
- Classys214150 · ₩1.8T₩27,200−1.98%
- Kctech281820 · ₩1.7T₩86,400−8.67%
- Park Systems140860 · ₩1.6T₩223,000−6.30%
- Seers458870 · ₩1.1T₩27,850+17.51%
- DI003160 · ₩1T₩36,100−3.35%
- Curiox Biosystems445680 · ₩1T₩58,700−2.17%
- LivsMed491000 · ₩923B₩36,550−3.82%
Recent filings
See all- Half-year report (Jun 2026)Aug 14, 2026
- 5%+ holding reportJul 31, 2026
- Amended: Annual report (Dec 2025)Jul 9, 2026
- Insider shareholding reportJun 30, 2026
- Investor relations (IR) eventJun 23, 2026
Titles in Korean until English translations are added.
Also known as: RecensMedical / 리센스메디컬 / 394420 / KRX:394420
Source: KRX statistical information